1. Home
  2. RXRX vs PHIN Comparison

RXRX vs PHIN Comparison

Compare RXRX & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • PHIN
  • Stock Information
  • Founded
  • RXRX 2013
  • PHIN 2023
  • Country
  • RXRX United States
  • PHIN United States
  • Employees
  • RXRX N/A
  • PHIN N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • PHIN
  • Sector
  • RXRX Health Care
  • PHIN
  • Exchange
  • RXRX Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • RXRX 1.8B
  • PHIN 1.8B
  • IPO Year
  • RXRX 2021
  • PHIN N/A
  • Fundamental
  • Price
  • RXRX $5.03
  • PHIN $42.57
  • Analyst Decision
  • RXRX Buy
  • PHIN Buy
  • Analyst Count
  • RXRX 5
  • PHIN 5
  • Target Price
  • RXRX $7.00
  • PHIN $52.20
  • AVG Volume (30 Days)
  • RXRX 29.8M
  • PHIN 456.1K
  • Earning Date
  • RXRX 08-07-2025
  • PHIN 07-29-2025
  • Dividend Yield
  • RXRX N/A
  • PHIN 2.55%
  • EPS Growth
  • RXRX N/A
  • PHIN N/A
  • EPS
  • RXRX N/A
  • PHIN 1.75
  • Revenue
  • RXRX $59,790,000.00
  • PHIN $3,336,000,000.00
  • Revenue This Year
  • RXRX $23.51
  • PHIN N/A
  • Revenue Next Year
  • RXRX $53.87
  • PHIN $1.55
  • P/E Ratio
  • RXRX N/A
  • PHIN $24.19
  • Revenue Growth
  • RXRX 29.32
  • PHIN N/A
  • 52 Week Low
  • RXRX $3.79
  • PHIN $36.25
  • 52 Week High
  • RXRX $12.36
  • PHIN $57.23
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 52.35
  • PHIN 48.11
  • Support Level
  • RXRX $4.78
  • PHIN $41.62
  • Resistance Level
  • RXRX $6.07
  • PHIN $43.47
  • Average True Range (ATR)
  • RXRX 0.45
  • PHIN 1.12
  • MACD
  • RXRX 0.04
  • PHIN -0.13
  • Stochastic Oscillator
  • RXRX 44.97
  • PHIN 36.51

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

Share on Social Networks: